Cam Gallagher, Director at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 20,000 shares at $52.74 ($1.0M) on 2022-02-15, disclosed to the SEC on 2022-02-15.
Open-market sale of $1.0M ZNTL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.22 | 3,264 | $167K | 16.1% |
| 2 | $51.22 | 3,264 | $167K | 16.1% |
| 3 | $52.15 | 5,366 | $280K | 26.9% |
| 4 | $52.15 | 5,366 | $280K | 26.9% |
| 5 | $52.74 | 1,370 | $72K | 7.0% |
| 6 | $52.74 | 1,370 |
| $72K |
| 7.0% |
| Total | $51.93 avg | 20,000 | $1.0M | 100% |
| Filing → |
| ZNTL | SELL | 2024-02-12 | $13K | — | Filing → |
| ZNTL | SELL | 2024-02-05 | $267K | — | Filing → |
| ZNTL | SELL | 2023-05-31 | $1.5M | — | Filing → |